
Yevgeny Valenrod
Examiner (ID: 18322)
| Most Active Art Unit | 1621 |
| Art Unit(s) | 1628, 1621, 1672 |
| Total Applications | 1499 |
| Issued Applications | 1070 |
| Pending Applications | 102 |
| Abandoned Applications | 358 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14712685
[patent_doc_number] => 20190247406
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-15
[patent_title] => PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING ISCHEMIA-REPERFUSION INJURY, CONTAINING BILE ACID
[patent_app_type] => utility
[patent_app_number] => 16/345483
[patent_app_country] => US
[patent_app_date] => 2017-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5909
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16345483
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/345483 | Pharmaceutical composition for preventing or treating ischemic-reperfusion injury comprising bile acids | Oct 30, 2017 | Issued |
Array
(
[id] => 12675484
[patent_doc_number] => 20180116994
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-03
[patent_title] => SARMS AND METHOD OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/786811
[patent_app_country] => US
[patent_app_date] => 2017-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52562
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15786811
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/786811 | SARMs and method of use thereof | Oct 17, 2017 | Issued |
Array
(
[id] => 12621354
[patent_doc_number] => 20180098948
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-12
[patent_title] => CANNABINOID-CONTAINING COMPLEX MIXTURES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
[patent_app_type] => utility
[patent_app_number] => 15/729565
[patent_app_country] => US
[patent_app_date] => 2017-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11599
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15729565
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/729565 | Cannabinoid-containing complex mixtures for the treatment of neurodegenerative diseases | Oct 9, 2017 | Issued |
Array
(
[id] => 12546051
[patent_doc_number] => 10011555
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-03
[patent_title] => Methods of treating Parkinson's disease
[patent_app_type] => utility
[patent_app_number] => 15/727638
[patent_app_country] => US
[patent_app_date] => 2017-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 16
[patent_no_of_words] => 7264
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15727638
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/727638 | Methods of treating Parkinson's disease | Oct 8, 2017 | Issued |
Array
(
[id] => 14960473
[patent_doc_number] => 20190307714
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-10
[patent_title] => METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS
[patent_app_type] => utility
[patent_app_number] => 16/335662
[patent_app_country] => US
[patent_app_date] => 2017-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15328
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16335662
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/335662 | Methods and pharmaceutical compositions for the treatment of non-alcoholic steatohepatitis | Sep 27, 2017 | Issued |
Array
(
[id] => 12136992
[patent_doc_number] => 20180015076
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-18
[patent_title] => 'METHODS OF INCREASING TONIC INHIBITION AND TREATING SECONDARY INSOMNIA'
[patent_app_type] => utility
[patent_app_number] => 15/716726
[patent_app_country] => US
[patent_app_date] => 2017-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22603
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15716726
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/716726 | METHODS OF INCREASING TONIC INHIBITION AND TREATING SECONDARY INSOMNIA | Sep 26, 2017 | Abandoned |
Array
(
[id] => 12185395
[patent_doc_number] => 20180044331
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-15
[patent_title] => 'PIPERAZINE DERIVATIVES FOR TREATING DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 15/708315
[patent_app_country] => US
[patent_app_date] => 2017-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 22826
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15708315
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/708315 | Piperazine derivatives for treating disorders | Sep 18, 2017 | Issued |
Array
(
[id] => 12136988
[patent_doc_number] => 20180015069
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-18
[patent_title] => 'ENHANCING AUTOPHAGY OR INCREASING LONGEVITY BY ADMINISTRATION OF UROLITHINS OR PRECURSORS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/701057
[patent_app_country] => US
[patent_app_date] => 2017-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 40
[patent_no_of_words] => 92739
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15701057
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/701057 | ENHANCING AUTOPHAGY OR INCREASING LONGEVITY BY ADMINISTRATION OF UROLITHINS OR PRECURSORS THEREOF | Sep 10, 2017 | Abandoned |
Array
(
[id] => 13325885
[patent_doc_number] => 20180214480
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-02
[patent_title] => PHARMACEUTICAL-GRADE FERRIC ORGANIC COMPOUNDS, USES THEREOF AND METHODS OF MAKING SAME
[patent_app_type] => utility
[patent_app_number] => 15/699025
[patent_app_country] => US
[patent_app_date] => 2017-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10897
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15699025
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/699025 | PHARMACEUTICAL-GRADE FERRIC ORGANIC COMPOUNDS, USES THEREOF AND METHODS OF MAKING SAME | Sep 7, 2017 | Abandoned |
Array
(
[id] => 12305634
[patent_doc_number] => 09938243
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-10
[patent_title] => Compounds for affinity chromatography and for extending the half-life of a therapeutic agent
[patent_app_type] => utility
[patent_app_number] => 15/698020
[patent_app_country] => US
[patent_app_date] => 2017-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 10515
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15698020
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/698020 | Compounds for affinity chromatography and for extending the half-life of a therapeutic agent | Sep 6, 2017 | Issued |
Array
(
[id] => 17103104
[patent_doc_number] => 11123292
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-21
[patent_title] => Use of biocompatible microdroplets for the treatment of atherosclerosis, heart disease and stroke
[patent_app_type] => utility
[patent_app_number] => 15/691760
[patent_app_country] => US
[patent_app_date] => 2017-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 17727
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15691760
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/691760 | Use of biocompatible microdroplets for the treatment of atherosclerosis, heart disease and stroke | Aug 30, 2017 | Issued |
Array
(
[id] => 12217473
[patent_doc_number] => 20180055833
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-01
[patent_title] => 'OPHTHALMIC COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 15/691607
[patent_app_country] => US
[patent_app_date] => 2017-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6263
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15691607
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/691607 | Ophthalmic compositions | Aug 29, 2017 | Issued |
Array
(
[id] => 14621629
[patent_doc_number] => 20190224182
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-25
[patent_title] => HAIR FOLLICLE STEM CELL ACTIVATION AND HAIR GROWTH
[patent_app_type] => utility
[patent_app_number] => 16/327966
[patent_app_country] => US
[patent_app_date] => 2017-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45090
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 897
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16327966
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/327966 | Hair follicle stem cell activation and hair growth | Aug 24, 2017 | Issued |
Array
(
[id] => 13354545
[patent_doc_number] => 20180228812
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-16
[patent_title] => THERAPEUTICAL USES OF ESLICARBAZEPINE
[patent_app_type] => utility
[patent_app_number] => 15/677165
[patent_app_country] => US
[patent_app_date] => 2017-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7531
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15677165
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/677165 | THERAPEUTICAL USES OF ESLICARBAZEPINE | Aug 14, 2017 | Abandoned |
Array
(
[id] => 12562833
[patent_doc_number] => 10016513
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-10
[patent_title] => Stabilizing excipients for therapeutic protein formulations
[patent_app_type] => utility
[patent_app_number] => 15/676168
[patent_app_country] => US
[patent_app_date] => 2017-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14924
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15676168
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/676168 | Stabilizing excipients for therapeutic protein formulations | Aug 13, 2017 | Issued |
Array
(
[id] => 12975550
[patent_doc_number] => 20170340600
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-30
[patent_title] => COMPOSITIONS, METHODS OF USE, AND METHODS OF TREATMENT
[patent_app_type] => utility
[patent_app_number] => 15/672817
[patent_app_country] => US
[patent_app_date] => 2017-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22328
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15672817
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/672817 | Compositions, methods of use, and methods of treatment | Aug 8, 2017 | Issued |
Array
(
[id] => 16891996
[patent_doc_number] => 11033522
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-15
[patent_title] => Free amino acid preparation and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/673214
[patent_app_country] => US
[patent_app_date] => 2017-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3911
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15673214
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/673214 | Free amino acid preparation and uses thereof | Aug 8, 2017 | Issued |
Array
(
[id] => 12387711
[patent_doc_number] => 09963475
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-08
[patent_title] => Anthracene-9, 10-dione dioxime compound prodrugs and their uses
[patent_app_type] => utility
[patent_app_number] => 15/671780
[patent_app_country] => US
[patent_app_date] => 2017-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23749
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15671780
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/671780 | Anthracene-9, 10-dione dioxime compound prodrugs and their uses | Aug 7, 2017 | Issued |
Array
(
[id] => 17539821
[patent_doc_number] => 11304925
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-04-19
[patent_title] => Cannabis composition
[patent_app_type] => utility
[patent_app_number] => 15/780579
[patent_app_country] => US
[patent_app_date] => 2017-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 9176
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15780579
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/780579 | Cannabis composition | Aug 2, 2017 | Issued |
Array
(
[id] => 14865189
[patent_doc_number] => 20190282836
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-19
[patent_title] => TREATMENT AND PREVENTION OF SLEEP DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/318686
[patent_app_country] => US
[patent_app_date] => 2017-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39094
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -95
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16318686
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/318686 | Treatment and prevention of sleep disorders | Jul 24, 2017 | Issued |